UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029538
Receipt number R000032853
Scientific Title Visit-to-Visit Blood Pressure Variability and Geriatric Syndrome in Type 2 Diabetes
Date of disclosure of the study information 2017/11/01
Last modified on 2019/05/07 08:51:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Visit-to-Visit Blood Pressure Variability and Geriatric Syndrome in Type 2 Diabetes

Acronym

VIVA G Study

Scientific Title

Visit-to-Visit Blood Pressure Variability and Geriatric Syndrome in Type 2 Diabetes

Scientific Title:Acronym

VIVA G Study

Region

Japan


Condition

Condition

Type 2 Diabetes Mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the association with visit-to-visit blood pressure variability and geriatric syndromes

Basic objectives2

Others

Basic objectives -Others

Among geriatric syndromes, to investigate cognitive function and falls and fractures in particular

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The association between visit-to-visit blood pressure variability and cognitive function

Key secondary outcomes

The association between visit-to-visit blood pressure variability and falls and fractures


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The participant has been visiting the hospital for treatment of type 2 diabetes for at least 12 times in the past three years (at intervals of two weeks or more and 6 months or less) and has blood pressure measured.

Key exclusion criteria

On hemodialysis

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Yoshihide
Middle name
Last name Ichigi

Organization

Kanazawa Hospital

Division name

Medical Staff

Zip code

236-0021

Address

2-8-3 Deiki, Kanazawa-ku, Yokohama-shi

TEL

045-781-2611

Email

yichigi2000@yahoo.co.jp


Public contact

Name of contact person

1st name Hideyuki
Middle name
Last name Yoshino

Organization

Kanazawa Hospital

Division name

Division of Administration

Zip code

236-0021

Address

2-8-3 Deiki, Kanazawa-ku, Yokohama-shi

TEL

045-781-2611

Homepage URL


Email

hideyuki_yoshino@keisuikai.or.jp


Sponsor or person

Institute

Kanazawa Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

YCU Center for Novel and Exploratory Clinical Trials

Address

5th floor, 1-1-1 Fukuura Kanazawa-ku, Yokohama-shi

Tel

045-370-7991

Email

nextjim1@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢病院(神奈川県)/Kanazawa Hospital (Kanagawa Prefecture)


Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 11 Month 01 Day

Date of IRB

2017 Year 11 Month 28 Day

Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date

2018 Year 07 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Being analyzed


Management information

Registered date

2017 Year 10 Month 13 Day

Last modified on

2019 Year 05 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032853


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name